Physician profile
Ronald E Moore
NPI 1669542148
$31,918.78
in general payments reported to CMS, 2019-2025
24 companies · $5,426 in 2025
The $5,426 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,971 · 2020: $826 · 2021: $1,739 · 2022: $3,369 · 2023: $3,546 · 2024: $15K · 2025: $5,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $6,299 · Travel and Lodging: $1,932 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,624.11 |
| Food and Beverage | $6,299.32 |
| Travel and Lodging | $1,932.26 |
| Education | $157.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $18,018.73 | 2022-2025 | Zynrelef, Aponvie |
| Intuitive Surgical, INC. | $5,767.71 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $3,204.43 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Ethicon US, LLC | $1,694.13 | 2019-2025 | Vistaseal, Echelon; Endopath, Harmonic |
| Davol INC. | $737.07 | 2020-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $474.61 | 2019-2024 | |
| Biom'Up France Sas | $264.92 | 2021 | |
| Kerecis Limited | $200.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $162.88 | 2022 | |
| Innovation Technologies INC | $158.77 | 2024 | Irrisept |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Kci USA, INC. | $135.42 | 2019 | |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $126.29 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2022 | |
| Merck Sharp & Dohme LLC | $114.52 | 2019 | |
| Aroa Biosurgery Incorporated | $100.00 | 2025 | |
| Csl Behring | $40.06 | 2019-2024 | Kcentra |
| Covidien Lp | $40.00 | 2019 | |
| Smith+Nephew, INC. | $39.84 | 2022 | |
| Olympus America INC. | $26.86 | 2023 | Olympus |
| Portola Pharmaceuticals, LLC | $26.75 | 2019 | |
| Integra Lifesciences Corporation | $25.88 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.